Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.17%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+1.87%XMRUSDT-0.45%DOGEUSD+69.80%LINKUSD+2.16%XLMUSD-0.56%BCHUSDT-0.25%LTCUSD+68.40%UNIUSD-0.80%TONUSD+79.92%SUIUSD+1.58%HBARUSDT-0.11%TAOUSDT+2.71%AAVEUSD+1.51%ONDOUSDT+1.09%DOTUSDT+1.15%ICPUSDT+1.84%WLDUSDT+2.44%ARBUSDT+2.38%ATOMUSDT+1.98%INJUSDT+4.96%STXUSDT+4.58%PYTHUSDT+3.03%TIAUSDT+3.05%FETUSDT-0.17%SEIUSDT+0.59%JUPUSDT+1.87%GRTUSDT+0.73%OPUSDT+1.55%IOTAUSDT+1.72%POLUSDT-0.05%WIFUSDT+2.36%AXSUSDT+0.01%EOSUSDT+0.68%IMXUSDT+0.09%FARTCOINUSDT+1.22%GALAUSDT+2.69%DYDXUSDT+0.53%ORDIUSDT+2.36%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.17%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+1.87%XMRUSDT-0.45%DOGEUSD+69.80%LINKUSD+2.16%XLMUSD-0.56%BCHUSDT-0.25%LTCUSD+68.40%UNIUSD-0.80%TONUSD+79.92%SUIUSD+1.58%HBARUSDT-0.11%TAOUSDT+2.71%AAVEUSD+1.51%ONDOUSDT+1.09%DOTUSDT+1.15%ICPUSDT+1.84%WLDUSDT+2.44%ARBUSDT+2.38%ATOMUSDT+1.98%INJUSDT+4.96%STXUSDT+4.58%PYTHUSDT+3.03%TIAUSDT+3.05%FETUSDT-0.17%SEIUSDT+0.59%JUPUSDT+1.87%GRTUSDT+0.73%OPUSDT+1.55%IOTAUSDT+1.72%POLUSDT-0.05%WIFUSDT+2.36%AXSUSDT+0.01%EOSUSDT+0.68%IMXUSDT+0.09%FARTCOINUSDT+1.22%GALAUSDT+2.69%DYDXUSDT+0.53%ORDIUSDT+2.36%NOTUSDT+1.19%RONINUSDT+1.91%
VI

Viatris Inc. (VTRS)

NASDAQ • Healthcare

$19.63
-$0.25 (-1.3%)
Market closed

Last close at November 20, 2026 at 21:00 UTC

Open$19.91
Day Range$19.43 - $20.1
Avg. Volume (3M)10M
Market Cap$22.5B
52 Week Range
$10.39$21.2

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$3.7B100%
Gross Profitminus cost of goods$1.4B38%
Operating Incomeminus R&D and overhead$261.5M7%

In plain terms: out of every $100 in revenue, Viatris Inc. currently loses $9.

Fundamentals & Financials

Revenue (TTM)
$14.7B
Net Income (TTM)
-$607.8M
EPS (TTM)
-$0.53
ROA (TTM)
-1.75%
Current Ratio
1.55
Dividend Yield
0.68%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+17.5%Q2 2026$0.59
+14.8%Q3 2026$0.69
+11.5%Q4 2026$0.71

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +11.5%

Viatris topped EPS expectations while revenue came in line in the third fiscal quarter of 2026, reported November 5, 2026, with adjusted EPS of $0.71 topping the $0.64 estimate (+11%) even as revenue of $3.749 billion was in line with a $3.786 billion estimate (-0.96%). On a year-over-year basis, revenue slipped ~0% to roughly $3.7 billion from about $3.8 billion a year ago, while gross profit was about $1.4 billion and gross margin stood near 38%. The quarter’s GAAP net loss widened to roughly $325 million (down -153.7% year over year) versus a net loss of about $128 million a year ago. Viatris generated about $899 million of operating cash flow, and it returned cash through roughly $150 million of share repurchases alongside about $138 million paid in dividends. For the next period, consensus calls for EPS of $0.60 on revenue of $3.719 billion.

View full earnings history

About Viatris Inc.

Viatris Inc. operates in healthcare as a maker of branded, generic, and specialty medicines, trading on NASDAQ under VTRS. Its portfolio spans treatments from Lyrica and Lipitor to biosimilars and raw pharmaceutical ingredients, and it generated $14.3 billion of revenue in FY2025.

Name
Viatris Inc.
CEO
Scott Andrew Smith
Industry
Healthcare
Year Founded
1961
Employees
30,000

Today's Snapshot

AI-generated

The day ended with VTRS 1.3% lower at 19.63, while its sector was flat. Zacks, an investment research firm, upgraded Viatris to Strong Buy, citing improving earnings prospects.

Trading Volume

Below 10d avg (11.1M)

9.2M

vs S&P 500 Today

Outperforming Market

+2.23%

Updated: November 20, 2026 at 21:19 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
VTRS, at about 19.63, shows a constructive trend backdrop despite short-term softness as the stock sits slightly below near-term averages but above its 50/100/200-day levels, indicating longer-term support. Trend strength is strong with ADX about 33, while momentum readings are mixed: RSI near neutral, MACD modestly positive, and short-term momentum slightly negative. Volatility is moderate (ATR roughly 0.56) and volume metrics show some divergence with on-balance volume not confirming every move; the pivot at 19.97 is just overhead. Technical takeaway: buy — strong trend and longer-term moving-average support counter a short-term pullback.
All signals
  • EMA (5 indicators)$16.31 - $20.11
    Buy
  • RSI (14)52.16
    Neutral
  • Stochastic %K (14, 3, 3)50.39
    Neutral
  • MACD Level (12, 26)0.55
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.